Valuation: Macrogen, Inc.

Market Cap 119B 88.17M 78.57M 71.87M 65.45M 123M 8.33B 127M 863M 345M 4.41B 331M 324M 13.92B P/E 2026 *
14.7x
P/E 2027 * 7.41x
Enterprise Value 196M 145K 129K 118K 108K 203K 13.7M 208K 1.42M 568K 7.25M 544K 532K 22.89M EV / Sales 2026 *
0.94x
EV / Sales 2027 * 0.75x
Free-Float
79.78%
Yield 2026 *
4.55%
Yield 2027 * 4.55%
1 day+0.27%
1 week-2.14%
Current month+0.92%
1 month-12.63%
3 months-7.33%
6 months-32.18%
Current year-34.80%
1 week 10,600
Extreme 10600
11,230
1 month 10,600
Extreme 10600
12,620
Current year 10,440
Extreme 10440
20,900
1 year 10,440
Extreme 10440
20,900
3 years 10,440
Extreme 10440
26,700
5 years 10,440
Extreme 10440
31,250
10 years 10,440
Extreme 10440
54,900
Manager TitleAgeSince
Chief Executive Officer 59 2025-03-30
Chief Executive Officer 53 2026-03-30
Chief Executive Officer 74 2025-03-30
Director TitleAgeSince
Chairman 74 2010-10-09
Director/Board Member 59 -
Director/Board Member 53 2023-03-30
Date Insider Type Main position Quantity % Market Cap. Importance
4/9/25 Buy

Chief Executive Officer

1,100 0.0101%
2/7/25 Others 2,192 0.0202%
1/23/25 Others

Chief Financial Officer

95 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
+0.27%-2.14%-27.63%-36.16% 88.54M
+3.80%+8.47%+64.65%+77.70% 66.87B
+1.63%+6.76%+24.52%+104.31% 56.55B
+0.07%+2.39%+11.12%+75.17% 57.2B
+0.41%-5.07%+25.56%+34.32% 43.47B
-11.04%-5.87%+203.31%+701.67% 42.8B
+2.51%+3.72%+25.25%+110.71% 42.95B
+1.59%-6.02%+92.48%+79.95% 32.11B
+7.50%+13.28%+28.05%+64.46% 34.01B
-1.13%+12.15%-40.49%+337.67% 24.13B
Average +0.56%+3.67%+40.68%+154.98% 40.02B
Weighted average by Cap. +0.71%+3.91%+50.44%+161.38%

Financials

2026 *2027 *
Net sales 208B 154M 137M 126M 114M 215M 14.55B 221M 1.51B 603M 7.71B 578M 566M 24.32B 245B 181M 161M 148M 134M 253M 17.12B 260M 1.77B 709M 9.07B 680M 665M 28.61B
Net income 8.1B 5.99M 5.34M 4.88M 4.45M 8.38M 566M 8.61M 58.64M 23.45M 300M 22.48M 22M 946M 16.1B 11.9M 10.61M 9.7M 8.84M 16.66M 1.12B 17.1M 117M 46.61M 596M 44.68M 43.72M 1.88B
Net Debt 76.8B 56.78M 50.6M 46.28M 42.15M 79.45M 5.37B 81.59M 556M 222M 2.84B 213M 209M 8.97B 64.8B 47.91M 42.69M 39.05M 35.56M 67.04M 4.53B 68.84M 469M 188M 2.4B 180M 176M 7.57B
Projected Income Statement - Annual - Macrogen, Inc.
Logo Macrogen, Inc.
Macrogen Inc is a Korea-based company principally engaged in the genome analysis business. The Company’s main products include DNA sequencing, oligo synthesis, and microarray analysis. The Company also provides various genome-based research services such as single-cell analysis and metagenome analysis. In addition, the Company is engaged in the operation of genetically engineered mouse production, clinical genome analysis services, personal genome analysis services, and microbiome analysis services. The Company sells its products and services in domestic and overseas markets.
Employees
473
Date Price Change Volume
26-11-05 ₩11,000.00 +0.27% 12,284
26-11-04 ₩10,970.00 +1.01% 15,535
26-11-03 ₩10,860.00 -1.27% 12,027
26-11-02 ₩11,000.00 +0.92% 13,280
26-10-30 ₩10,900.00 -0.46% 10,630
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Macrogen, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
11,000.00KRW
Average target price
21,000.00KRW
Spread / Average Target
+90.91%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Macrogen, Inc.
  1. Stock Market
  2. Stocks
  3. A038290 Stock